Chemomab Therapeutics Ltd. Foreign Currency Transaction Gain (Loss), before Tax
Chemomab Therapeutics Ltd. (CMMB) reported Foreign Currency Transaction Gain (Loss), before Tax of -$40.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2020-03-17
- Chemomab Therapeutics Ltd. foreign currency transaction gain (loss), before tax for fiscal 2019 was -$40.00K.
- Chemomab Therapeutics Ltd. foreign currency transaction gain (loss), before tax for fiscal 2018 was -$474.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2019-12-31 | -$40.00K 10-K · filed 2020-03-17 |
| 2018-12-31 | -$474.00K 10-K · filed 2020-03-17 |